Categories Earnings, Finance

Earnings Summary: Highlights of T. Rowe Price Group’s Q2 2023 results

Investment management company T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) has announced financial results for the second quarter of 2023, reporting higher earnings and revenues.

  • Second-quarter net revenues increased 6.4% year-over-year to $1.61 billion from $1.51 billion a year earlier
  • Net income attributable to the company was $476.4 million in the three-month period, up 40% year-over-year
  • On a per-share basis, second-quarter earnings moved up to $2.06 per share from $1.46 per share last year
  • Adjusted net income was $2.02 per share in the June quarter, up 12.8% year-over-year
  • At the end of the quarter, the company had assets under management of $1.40 billion, up 6.8% year-over-year

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top